Camber Pharma Launches Generic Zomig®
Piscataway, NJ, January 9, 2015– Camber Pharmaceuticals announces that it has launched Zolmitriptan 2.5mg and 5mg tablets. The drug is the generic version of Zomig® tablet. Zolmitriptan is used to treat migraine headaches.
Zolmitriptan is available in a 6 count blister pack for 2.5mg and a 3 count blister pack for 5mg.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection





